List of Tables
Table 1. Global Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Injectables
Table 3. Key Players of Oral
Table 4. Key Players of Other
Table 5. Global Rare Autoinflammatory Diseases Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Rare Autoinflammatory Diseases Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Rare Autoinflammatory Diseases Drug Market Size by Region (US$ Million), 2021–2026
Table 8. Global Rare Autoinflammatory Diseases Drug Market Share by Region (2021–2026)
Table 9. Global Rare Autoinflammatory Diseases Drug Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Rare Autoinflammatory Diseases Drug Market Share by Region (2027–2032)
Table 11. Rare Autoinflammatory Diseases Drug Market Trends
Table 12. Rare Autoinflammatory Diseases Drug Market Drivers
Table 13. Rare Autoinflammatory Diseases Drug Market Challenges
Table 14. Rare Autoinflammatory Diseases Drug Market Restraints
Table 15. Global Rare Autoinflammatory Diseases Drug Revenue by Players (US$ Million), 2021–2026
Table 16. Global Rare Autoinflammatory Diseases Drug Market Share by Players (2021–2026)
Table 17. Global Top Rare Autoinflammatory Diseases Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Rare Autoinflammatory Diseases Drug Revenue, 2025
Table 18. Ranking of Global Top Rare Autoinflammatory Diseases Drug Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Rare Autoinflammatory Diseases Drug Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Rare Autoinflammatory Diseases Drug, Headquarters and Area Served
Table 21. Global Key Players of Rare Autoinflammatory Diseases Drug, Products and Applications
Table 22. Global Key Players of Rare Autoinflammatory Diseases Drug, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Rare Autoinflammatory Diseases Drug Market Size by Type (US$ Million), 2021–2026
Table 25. Global Rare Autoinflammatory Diseases Drug Revenue Market Share by Type (2021–2026)
Table 26. Global Rare Autoinflammatory Diseases Drug Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Rare Autoinflammatory Diseases Drug Revenue Market Share by Type (2027–2032)
Table 28. Global Rare Autoinflammatory Diseases Drug Market Size by Application (US$ Million), 2021–2026
Table 29. Global Rare Autoinflammatory Diseases Drug Revenue Market Share by Application (2021–2026)
Table 30. Global Rare Autoinflammatory Diseases Drug Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Rare Autoinflammatory Diseases Drug Revenue Market Share by Application (2027–2032)
Table 32. North America Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2021–2026
Table 34. North America Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Rare Autoinflammatory Diseases Drug Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Rare Autoinflammatory Diseases Drug Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Rare Autoinflammatory Diseases Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Rare Autoinflammatory Diseases Drug Market Size by Country (US$ Million), 2027–2032
Table 47. Novartis Company Details
Table 48. Novartis Business Overview
Table 49. Novartis Rare Autoinflammatory Diseases Drug Product
Table 50. Novartis Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 51. Novartis Recent Development
Table 52. Abbvie Company Details
Table 53. Abbvie Business Overview
Table 54. Abbvie Rare Autoinflammatory Diseases Drug Product
Table 55. Abbvie Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 56. Abbvie Recent Development
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Rare Autoinflammatory Diseases Drug Product
Table 60. Abbott Laboratories Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 61. Abbott Laboratories Recent Development
Table 62. Regeneron Pharmaceuticals Company Details
Table 63. Regeneron Pharmaceuticals Business Overview
Table 64. Regeneron Pharmaceuticals Rare Autoinflammatory Diseases Drug Product
Table 65. Regeneron Pharmaceuticals Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 66. Regeneron Pharmaceuticals Recent Development
Table 67. Swedish Orphan Biovitrum AB Company Details
Table 68. Swedish Orphan Biovitrum AB Business Overview
Table 69. Swedish Orphan Biovitrum AB Rare Autoinflammatory Diseases Drug Product
Table 70. Swedish Orphan Biovitrum AB Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 71. Swedish Orphan Biovitrum AB Recent Development
Table 72. Pfizer, Inc. Company Details
Table 73. Pfizer, Inc. Business Overview
Table 74. Pfizer, Inc. Rare Autoinflammatory Diseases Drug Product
Table 75. Pfizer, Inc. Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 76. Pfizer, Inc. Recent Development
Table 77. Bausch Health Company Details
Table 78. Bausch Health Business Overview
Table 79. Bausch Health Rare Autoinflammatory Diseases Drug Product
Table 80. Bausch Health Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 81. Bausch Health Recent Development
Table 82. Mallinckrodt Company Details
Table 83. Mallinckrodt Business Overview
Table 84. Mallinckrodt Rare Autoinflammatory Diseases Drug Product
Table 85. Mallinckrodt Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 86. Mallinckrodt Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Rare Autoinflammatory Diseases Drug Product
Table 90. Johnson & Johnson Revenue in Rare Autoinflammatory Diseases Drug Business (US$ Million), 2021–2026
Table 91. Johnson & Johnson Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Rare Autoinflammatory Diseases Drug Picture
Figure 2. Global Rare Autoinflammatory Diseases Drug Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Rare Autoinflammatory Diseases Drug Market Share by Type: 2025 vs 2032
Figure 4. Injectables Features
Figure 5. Oral Features
Figure 6. Other Features
Figure 7. Global Rare Autoinflammatory Diseases Drug Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Rare Autoinflammatory Diseases Drug Market Share by Application: 2025 vs 2032
Figure 9. Ulcerative Colitis Case Studies
Figure 10. Juvenile Rheumatoid Arthritis Case Studies
Figure 11. Psoriatic Arthritis Case Studies
Figure 12. Other Indications Case Studies
Figure 13. Rare Autoinflammatory Diseases Drug Report Years Considered
Figure 14. Global Rare Autoinflammatory Diseases Drug Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 15. Global Rare Autoinflammatory Diseases Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Rare Autoinflammatory Diseases Drug Market Share by Region: 2025 vs 2032
Figure 17. Global Rare Autoinflammatory Diseases Drug Market Share by Players in 2025
Figure 18. Global Rare Autoinflammatory Diseases Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Rare Autoinflammatory Diseases Drug Revenue in 2025
Figure 20. North America Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. North America Rare Autoinflammatory Diseases Drug Market Share by Country (2021–2032)
Figure 22. United States Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Canada Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Rare Autoinflammatory Diseases Drug Market Share by Country (2021–2032)
Figure 26. Germany Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. France Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. U.K. Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Italy Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Russia Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Ireland Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Rare Autoinflammatory Diseases Drug Market Share by Region (2021–2032)
Figure 34. China Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Japan Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. South Korea Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Southeast Asia Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. India Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Australia & New Zealand Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Rare Autoinflammatory Diseases Drug Market Share by Country (2021–2032)
Figure 42. Mexico Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Brazil Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Rare Autoinflammatory Diseases Drug Market Share by Country (2021–2032)
Figure 46. Israel Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Saudi Arabia Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. UAE Rare Autoinflammatory Diseases Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Novartis Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 50. Abbvie Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 51. Abbott Laboratories Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 52. Regeneron Pharmaceuticals Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 53. Swedish Orphan Biovitrum AB Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 54. Pfizer, Inc. Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 55. Bausch Health Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 56. Mallinckrodt Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 57. Johnson & Johnson Revenue Growth Rate in Rare Autoinflammatory Diseases Drug Business (2021–2026)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
